Raymond James Financial Inc. purchased a new position in Global Medical REIT Inc. (NYSE:GMRE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 185,224 shares of the company's stock, valued at approximately $1,430,000. Raymond James Financial Inc. owned 0.28% of Global Medical REIT at the end of the most recent reporting period.
Several other hedge funds also recently made changes to their positions in the stock. Quantinno Capital Management LP bought a new stake in Global Medical REIT during the 3rd quarter worth approximately $138,000. Zacks Investment Management raised its position in shares of Global Medical REIT by 12.9% in the third quarter. Zacks Investment Management now owns 14,803 shares of the company's stock worth $147,000 after buying an additional 1,696 shares in the last quarter. Intech Investment Management LLC purchased a new stake in shares of Global Medical REIT in the third quarter worth $150,000. Dynamic Technology Lab Private Ltd bought a new stake in Global Medical REIT during the third quarter valued at $206,000. Finally, Proficio Capital Partners LLC purchased a new position in Global Medical REIT during the fourth quarter worth about $178,000. 57.52% of the stock is currently owned by hedge funds and other institutional investors.
Analysts Set New Price Targets
Separately, B. Riley started coverage on shares of Global Medical REIT in a report on Thursday. They issued a "neutral" rating and a $9.00 price target on the stock.
Check Out Our Latest Stock Analysis on GMRE
Global Medical REIT Trading Down 3.7 %
Shares of GMRE traded down $0.30 during mid-day trading on Friday, hitting $7.73. 895,797 shares of the company's stock traded hands, compared to its average volume of 430,531. The company has a quick ratio of 0.28, a current ratio of 0.28 and a debt-to-equity ratio of 1.26. The firm has a market capitalization of $516.58 million, a P/E ratio of -386.06, a PEG ratio of 1.43 and a beta of 1.12. The business's 50-day moving average price is $8.40 and its 200-day moving average price is $8.61. Global Medical REIT Inc. has a 1 year low of $7.33 and a 1 year high of $10.46.
Global Medical REIT (NYSE:GMRE - Get Free Report) last issued its quarterly earnings data on Thursday, February 27th. The company reported $0.22 EPS for the quarter, topping the consensus estimate of $0.01 by $0.21. The business had revenue of $35.16 million during the quarter, compared to analyst estimates of $34.87 million. Global Medical REIT had a net margin of 3.23% and a return on equity of 0.86%. As a group, sell-side analysts forecast that Global Medical REIT Inc. will post 0.81 EPS for the current fiscal year.
Global Medical REIT Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Wednesday, April 9th. Shareholders of record on Friday, March 21st will be issued a dividend of $0.21 per share. The ex-dividend date of this dividend is Friday, March 21st. This represents a $0.84 dividend on an annualized basis and a dividend yield of 10.87%. Global Medical REIT's dividend payout ratio (DPR) is 8,400.00%.
Global Medical REIT Company Profile
(
Free Report)
Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.
Recommended Stories

Before you consider Global Medical REIT, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Global Medical REIT wasn't on the list.
While Global Medical REIT currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.